Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on Sep 07, 2026 - 2:44PM >>   ABB 7382.5 [ -0.50 ]ACC 1270 [ -1.05 ]AMBUJA CEM 399.9 [ -1.38 ]ASIAN PAINTS 2496.25 [ -1.25 ]AXIS BANK 1264.45 [ -0.67 ]BAJAJ AUTO 11794.8 [ -1.06 ]BANKOFBARODA 236.75 [ -1.02 ]BHARTI AIRTE 1847.35 [ 0.29 ]BHEL 421.05 [ -2.84 ]BPCL 311.9 [ -1.20 ]BRITANIAINDS 5021.2 [ -1.62 ]CIPLA 1389.9 [ 0.35 ]COAL INDIA 417.2 [ 0.70 ]COLGATEPALMO 1812.1 [ -1.30 ]DABUR INDIA 374.55 [ -1.50 ]DLF 676.25 [ -0.73 ]DRREDDYSLAB 1151.5 [ -0.22 ]GAIL 175.45 [ 1.24 ]GRASIM INDS 3298.7 [ -0.44 ]HCLTECHNOLOG 1274.1 [ -1.54 ]HDFC BANK 710.7 [ -0.34 ]HEROMOTOCORP 5299.5 [ -0.07 ]HIND.UNILEV 1969.05 [ -0.25 ]HINDALCO 1003 [ -1.07 ]ICICI BANK 1426.3 [ 0.23 ]INDIANHOTELS 717.45 [ -0.18 ]INDUSINDBANK 997.65 [ -0.83 ]INFOSYS 1087.75 [ -3.74 ]ITC LTD 263.8 [ -0.11 ]JINDALSTLPOW 1145 [ -1.55 ]KOTAK BANK 423.45 [ -0.33 ]L&T 3984.7 [ 0.47 ]LUPIN 2100.9 [ -0.48 ]MAH&MAH 3155 [ -0.44 ]MARUTI SUZUK 12780 [ 0.63 ]MTNL 26.27 [ -1.13 ]NESTLE 1400.7 [ -1.36 ]NIIT 97.95 [ -1.06 ]NMDC 84.26 [ -0.46 ]NTPC 331.05 [ -0.47 ]ONGC 233.3 [ -0.66 ]PNB 116.1 [ -0.60 ]POWER GRID 267.6 [ 0.60 ]RIL 1305.05 [ -1.28 ]SBI 1004.7 [ -1.21 ]SESA GOA 268.6 [ -1.25 ]SHIPPINGCORP 294 [ -0.39 ]SUNPHRMINDS 1885 [ -0.74 ]TATA CHEM 616.05 [ -1.49 ]TATA GLOBAL 1019.25 [ 0.72 ]TATA MOTORS 307.8 [ -1.35 ]TATA STEEL 184.8 [ -2.22 ]TATAPOWERCOM 364.25 [ -1.02 ]TCS 2264 [ -1.60 ]TECH MAHINDR 1560.8 [ -1.96 ]ULTRATECHCEM 11230.65 [ -1.03 ]UNITED SPIRI 1436.3 [ -2.62 ]WIPRO 173 [ -2.15 ]ZEETELEFILMS 85.59 [ -6.30 ] BSE NSE
You can view full text of the latest Auditor's Report for the company.

BSE: 532531ISIN: INE939A01011INDUSTRY: Pharmaceuticals

BSE   ` 1170.20   Open: 1042.05   Today's Range 1042.05
1184.30
+111.85 (+ 9.56 %) Prev Close: 1058.35 52 Week Range 769.60
1231.45
Year End :2026-03 

We have audited the standalone financial statements of
Strides Pharma Science Limited (the “Company”) which
comprise the standalone balance sheet as at 31 March 2026,
and the standalone statement of profit and loss (including
other comprehensive income), standalone statement of
changes in equity and standalone statement of cash flows
for the year then ended, and notes to the standalone financial
statements, including material accounting policies and other
explanatory information.

In our opinion and to the best of our information and according to
the explanations given to us, the aforesaid standalone financial
statements give the information required by the Companies Act,
2013 (“Act”) in the manner so required and give a true and fair view
in conformity with the accounting principles generally accepted
in India, of the state of affairs of the Company as at 31 March
2026, and its profit and other comprehensive loss, changes in
equity and its cash flows for the year ended on that date.

Basis for Opinion

We conducted our audit in accordance with the Standards
on Auditing (SAs) specified under Section 143(10) of the Act.

Our responsibilities under those SAs are further described in
the Auditor's Responsibilities for the Audit of the Standalone
Financial Statements section of our report. We are independent
of the Company in accordance with the Code of Ethics issued
by the Institute of Chartered Accountants of India together with
the ethical requirements that are relevant to our audit of the
standalone financial statements under the provisions of the
Act and the Rules thereunder, and we have fulfilled our other
ethical responsibilities in accordance with these requirements
and the Code of Ethics. We believe that the audit evidence we
have obtained is sufficient and appropriate to provide a basis for
our opinion on the standalone financial statements.

Key Audit Matters

Key audit matters are those matters that, in our professional
judgment, were of most significance in our audit of the standalone
financial statements of the current period. These matters were
addressed in the context of our audit of the standalone financial
statements as a whole, and in forming our opinion thereon, and
we do not provide a separate opinion on these matters.

Impairment testing of investments in subsidiaries:

Refer Material Accounting Policies and Note 8 to standalone financial statements

The key audit matter

How the matter was addressed in our audit

The net carrying amount of non-current

In view of the significance of the matter, following audit procedures were

investments in subsidiaries (aggregates to I
18,605.06 million) accounts for 34.48% of the total

applied, among others, to obtain sufficient audit evidence:

assets of the Company as at 31 March 2026.

• Assessed the design, implementation and operating effectiveness of the
relevant key controls around the impairment testing of the carrying value

Company's assessment of impairment contains
a number of parameters which involve significant
judgements in estimating the recoverable amount
of the Cash Generating Units (CGUs) to which

of investments in subsidiaries.

• Performed a retrospective analysis to assess the reasonableness of
Company's projections by comparing historical forecast to actual results.

such investments pertain. The recoverable

• Tested reasonability of projections used by the Company relating to the

amount of the CGUs, which is the value in use,

sales growth, operating costs, weighted average cost of capital, cashflow

has been derived from discounted forecast
cash flow models. These models use several
assumptions, including estimates of future sales
growth, operating costs, terminal growth rates

forecasts and verified overall mathematical accuracy of calculations.

• Engaged valuation specialists to assist in testing the reasonableness of
the valuation by evaluating the assumptions and methodologies used by
the Company, in particular for weighted average cost of capital, terminal

and weighted-average cost of capital. Changes in

growth rate, etc.

these assumptions, could lead to an impact on the

recoverable value of investment and accordingly

• Tested the Company's analysis of the sensitivity of the outcome of

impairment provision.

impairment to possible changes in key assumptions like terminal growth
rate, weighted average cost of capital, etc.

The impairment testing was significant to our
audit, because of the financial quantum of the
assets as well as the involvement of critical
judgements, estimates and assumptions.

• Assessed the adequacy and appropriateness of the disclosures in the
standalone financial statements, relating to the outcome of impairment
assessment, as required by the applicable Ind AS.

Impairment testing of goodwill

Refer Material Accounting Policies and Note 7(i) to standalone financial statements

The key audit matter

How the matter was addressed in our audit

The Company has goodwill of I 1,155.77 million as at 31 March

In view of the significance of the matter, following audit

2026, accounts for 2.14% of the total assets of the Company

procedures were applied, among others to obtain sufficient

as at 31 March 2026. This goodwill has been accounted in
previous year following the merger of one of its wholly owned

audit evidence:

subsidiary Strides Alathur Private Limited (formerly known as

• Assessed the design, implementation and operating

Vivimed Life Sciences Private Limited) pursuant to the Scheme

effectiveness of the Company's controls around the

of Amalgamation ('Scheme') approved by the National Company

impairment testing of carrying value of goodwill;

Law Tribunal ('NCL T') on 13 August 2024 with an appointed date

• Engaged valuation specialists to assist in testing the

of April 1, 2023. Upon filing with the Registrar of Companies, the

reasonableness of the valuation by evaluating the

Scheme became effective from 12 September 2024.

assumptions and methodologies used by the Company,
in particular for weighted average cost of capital, terminal

The annual impairment testing of goodwill is performed at the

growth rate, etc. This is based on our knowledge of the

level of the Cash Generating Unit (CGU) to which such goodwill
is allocated and was considered to be a key audit matter due

Company and the market in which the CGU operates.

to the complexity of the accounting requirements and the

• Evaluated the assumptions applied to key inputs such

significant judgement involved to estimate the recoverable

as sales growth, operating costs, weighted average cost

amount of the CGU. The recoverable amount of the CGU, which

of capital and terminal growth rates and verified overall

is the value in use has been derived from discounted forecast

mathematical accuracy of calculations;

cash flow models. These models use several assumptions,

• Performed a retrospective analysis of the accuracy of the

including estimates of future sales growth, operating costs,

Company's past projections by comparing historical forecast

terminal growth rates and weighted-average cost of capital.
Changes in these assumptions, could lead to an impact on the

to actual results;

recoverable value of investment and accordingly impairment

• Tested the Company's analysis of the sensitivity of

provision.

the outcome of impairment to possible changes in key
assumptions like terminal growth rate, weighted average

The impairment testing was significant to our audit, because of

cost of capital, etc.

the financial quantum of the assets as well as the involvement

• Assessed the adequacy and appropriateness of the

of critical judgements, estimates and assumptions.

disclosures in the standalone financial statements, relating
to the outcome of impairment assessment, as required by
the applicable Ind AS.

Information Other than the Standalone
Financial Statements and Auditor's Report
Thereon

The Company's Management and Board of Directors are
responsible for the other information. The other information
comprises the Management Reports such as Board's Report,
Management Discussion and Analysis, Corporate Governance
Report and Business Responsibility and Sustainability Report,
but does not include the financial statements and auditor's
report thereon, which we obtained prior to the date of this
auditor's report, and the remaining sections of the Company's
Annual Report, which are expected to be made available to us
after that date.

Our opinion on the standalone financial statements does not
cover the other information and we do not and will not express
any form of assurance conclusion thereon.

In connection with our audit of the standalone financial
statements, our responsibility is to read the other information
identified above and, in doing so, consider whether the other
information is materially inconsistent with the standalone
financial statements or our knowledge obtained in the audit, or
otherwise appears to be materially misstated.

If, based on the work we have performed on the other information
that we obtained prior to the date of this auditor's report, we
conclude that there is a material misstatement of this other
information, we are required to report that fact. We have nothing
to report in this regard.

When we read the remaining sections of the Annual Report, if
we conclude that there is a material misstatement therein, we
are required to communicate the matter to those charged with
governance and take necessary actions, as applicable under the
applicable laws and regulations.

Management's and Board of Directors'
Responsibilities for the Standalone Financial
Statements

The Company's Management and Board of Directors are
responsible for the matters stated in Section 134(5) of the Act
with respect to the preparation of these standalone financial
statements that give a true and fair view of the state of affairs,
profit/ loss and other comprehensive income, changes in
equity and cash flows of the Company in accordance with the
accounting principles generally accepted in India, including the
Indian Accounting Standards (Ind AS) specified under Section
133 of the Act. This responsibility also includes maintenance of
adequate accounting records in accordance with the provisions
of the Act for safeguarding of the assets of the Company and for
preventing and detecting frauds and other irregularities; selection
and application of appropriate accounting policies; making
judgments and estimates that are reasonable and prudent; and
design, implementation and maintenance of adequate internal
financial controls, that were operating effectively for ensuring
the accuracy and completeness of the accounting records,
relevant to the preparation and presentation of the standalone
financial statements that give a true and fair view and are free
from material misstatement, whether due to fraud or error.

In preparing the standalone financial statements, the
Management and Board of Directors are responsible for
assessing the Company's ability to continue as a going concern,
disclosing, as applicable, matters related to going concern and
using the going concern basis of accounting unless the Board of
Directors either intends to liquidate the Company or to cease
operations, or has no realistic alternative but to do so.

The Board of Directors is also responsible for overseeing the
Company's financial reporting process.

Auditor's Responsibilities for the Audit of
the Standalone Financial Statements

Our objectives are to obtain reasonable assurance about
whether the standalone financial statements as a whole are free
from material misstatement, whether due to fraud or error, and to
issue an auditor's report that includes our opinion. Reasonable
assurance is a high level of assurance, but is not a guarantee that
an audit conducted in accordance with SAs will always detect a
material misstatement when it exists. Misstatements can arise
from fraud or error and are considered material if, individually or
in the aggregate, they could reasonably be expected to influence
the economic decisions of users taken on the basis of these
standalone financial statements.

As part of an audit in accordance with SAs, we exercise
professional judgment and maintain professional skepticism
throughout the audit. We also:

• Identify and assess the risks of material misstatement of
the standalone financial statements, whether due to fraud
or error, design and perform audit procedures responsive to
those risks, and obtain audit evidence that is sufficient and
appropriate to provide a basis for our opinion. The risk of not
detecting a material misstatement resulting from fraud is
higher than for one resulting from error, as fraud may involve
collusion, forgery, intentional omissions, misrepresentations,
or the override of internal control.

• Obtain an understanding of internal control relevant to the
audit in order to design audit procedures that are appropriate
in the circumstances. Under Section 143(3)(i) of the Act, we
are also responsible for expressing our opinion on whether
the company has adequate internal financial controls with
reference to financial statements in place and the operating
effectiveness of such controls.

• Evaluate the appropriateness of accounting policies used
and the reasonableness of accounting estimates and related
disclosures made by the Management and Board of Directors.

• Conclude on the appropriateness of the Management
and Board of Directors use of the going concern basis of
accounting in preparation of standalone financial statements
and, based on the audit evidence obtained, whether a
material uncertainty exists related to events or conditions
that may cast significant doubt on the Company's ability to
continue as a going concern. If we conclude that a material
uncertainty exists, we are required to draw attention in our
auditor's report to the related disclosures in the standalone
financial statements or, if such disclosures are inadequate,
to modify our opinion. Our conclusions are based on the
audit evidence obtained up to the date of our auditor's report.
However, future events or conditions may cause the Company
to cease to continue as a going concern.

• Evaluate the overall presentation, structure and content of the
standalone financial statements, including the disclosures,
and whether the standalone financial statements represent
the underlying transactions and events in a manner that
achieves fair presentation.

We communicate with those charged with governance regarding,
among other matters, the planned scope and timing of the
audit and significant audit findings, including any significant
deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement
that we have complied with relevant ethical requirements
regarding independence, and to communicate with them
all relationships and other matters that may reasonably be
thought to bear on our independence, and where applicable,
related safeguards.

From the matters communicated with those charged with
governance, we determine those matters that were of most
significance in the audit of the standalone financial statements
of the current period and are therefore the key audit matters.
We describe these matters in our auditor's report unless law or
regulation precludes public disclosure about the matter or when,
in extremely rare circumstances, we determine that a matter
should not be communicated in our report because the adverse
consequences of doing so would reasonably be expected to
outweigh the public interest benefits of such communication.

Report on Other Legal and Regulatory
Requirements

1. As required by the Companies (Auditor's Report) Order,
2020 (“the Order”) issued by the Central Government
of India in terms of Section 143(11) of the Act, we give in
the “Annexure A” a statement on the matters specified in
paragraphs 3 and 4 of the Order, to the extent applicable.

2 A. As required by Section 143(3) of the Act, we report that:

a. We have sought and obtained all the information and
explanations which to the best of our knowledge and
belief were necessary for the purposes of our audit.

b. In our opinion, proper books of account as required
by law have been kept by the Company so far as it
appears from our examination of those books except
for the matters stated in the paragraph 2(B)(f) below
on reporting under Rule 11(g) of the Companies (Audit
and Auditors) Rules, 2014.

c. The standalone balance sheet, the standalone
statement of profit and loss (including other
comprehensive income), the standalone statement
of changes in equity and the standalone statement of
cash flows dealt with by this Report are in agreement
with the books of account.

d. In our opinion, the aforesaid standalone financial
statements comply with the Ind AS specified under
Section 133 of the Act.

e. On the basis of the written representations received
from the directors dated from 03 April 2026 to 21 April
2026 taken on record by the Board of Directors, none
of the directors is disqualified as on 31 March 2026
from being appointed as a director in terms of Section
164(2) of the Act.

f. the modification relating to the maintenance of
accounts and other matters connected therewith are
as stated in the paragraph 2(A)(b) above on reporting
under Section 143(3)(b) of the Act and paragraph 2B(f)
below on reporting under Rule 11(g) of the Companies
(Audit and Auditors) Rules, 2014.

g. With respect to the adequacy of the internal financial
controls with reference to financial statements of the
Company and the operating effectiveness of such
controls, refer to our separate Report in “Annexure B”.

B. With respect to the other matters to be included in
the Auditor's Report in accordance with Rule 11 of the
Companies (Audit and Auditors) Rules, 2014, in our opinion
and to the best of our information and according to the
explanations given to us:

a. The Company has disclosed the impact of pending
litigations as at 31 March 2026 on its financial position
in its standalone financial statements - Refer Note 42
to the standalone financial statements.

b. The Company did not have any long-term contracts
including derivative contracts for which there were
any material foreseeable losses.

c. There has been no delay in transferring amounts,
required to be transferred, to the Investor Education
and Protection Fund by the Company.

d (i) The management has represented that, to the best of
their knowledge and belief, as disclosed in the Note
51 to the standalone financial statements, no funds
have been advanced or loaned or invested (either
from borrowed funds or share premium or any other

sources or kind of funds) by the Company to or in
any other person(s) or entity(ies), including foreign
entities (“Intermediaries”), with the understanding,
whether recorded in writing or otherwise, that the
Intermediary shall directly or indirectly lend or invest
in other persons or entities identified in any manner
whatsoever by or on behalf of the Company (“Ultimate
Beneficiaries”) or provide any guarantee, security or
the like on behalf of the Ultimate Beneficiaries.

(ii) The management has represented that, to the best of
their knowledge and belief, as disclosed in the Note 51
to the standalone financial statements, no funds have
been received by the Company from any person(s)
or entity(ies), including foreign entities (“Funding
Parties”), with the understanding, whether recorded
in writing or otherwise, that the Company shall directly
or indirectly, lend or invest in other persons or entities
identified in any manner whatsoever by or on behalf
of the Funding Parties (“Ultimate Beneficiaries”) or
provide any guarantee, security or the like on behalf
of the Ultimate Beneficiaries.

(iii) Based on the audit procedures performed that
have been considered reasonable and appropriate
in the circumstances, nothing has come to our
notice that has caused us to believe that the
representations under sub-clause (i) and (ii) of Rule
11(e), as provided under (i) and (ii) above, contain any
material misstatement.

e. The final dividend paid by the Company during the
year, in respect of the same declared for the previous
year, is in accordance with Section 123 of the Act to
the extent it applies to payment of dividend.

As stated in Note 56 to the standalone financial
statements, the Board of Directors of the Company
has proposed final dividend for the year which is
subject to the approval of the members at the ensuing
Annual General Meeting. The dividend declared is in
accordance with Section 123 of the Act to the extent
it applies to declaration of dividend.

f. Based on our examination which included test
checks, the Company has used accounting softwares
for maintaining its books of account, which have a
feature of recording audit trail (edit log) facility and
the same has operated throughout the year for all
relevant transactions recorded in the respective
software except for modifications if any, made by
certain users with specific privileged access for direct
database changes.

Further, we did not come across any instance of the
audit trail feature being tampered with. Additionally,
where audit trail (edit log) facility was enabled and
operated in the prior years, the audit trail has been
preserved by the Company as per the statutory
requirements for record retention.

C. With respect to the matter to be included in the Auditor's
Report under Section 197(16) of the Act:

In our opinion and according to the information and
explanations given to us, the remuneration paid/payable
by the Company to its directors during the current year is
in accordance with the provisions of Section 197 of the Act.

The remuneration paid to any director is not in excess of the
limit laid down under Section 197 of the Act. The Ministry
of Corporate Affairs has not prescribed other details
under Section 197(16) of the Act which are required to be
commented upon by us.

For B S R & Co. LLP
Chartered Accountants
Firm's Registration No.:101248W/W-100022

G Prakash

Partner

Place: Bengaluru Membership No.: 099696

Date: 18 May 2026 ICAI UDIN:26099696BQRHAQ3519